Rapid report

Validity of surrogate endpoints in oncology (Rapid report)

Status: Status: Commission completed
Project no.: A10-05
Last updated: 24.11.2011

Report documents

Executive summary of the rapid report version 1.1

Validity of surrogate endpoints in oncology (Rapid report)

published on

24.11.2011

Document type

PDF document, 419 kB, EN, not accessible

Download file : Executive summary of the rapid report version 1.1 (PDF document, 419 kB, EN, not accessible)
Rapid Report version 1.1

Validity of surrogate endpoints in oncology (Rapid report)

published on

24.11.2011

Document type

PDF document, 2 MB, DE, not accessible

Download file : Rapid Report version 1.1 (PDF document, 2 MB, DE, not accessible)
Executive summary

Validity of surrogate endpoints in oncology (Rapid report)

published on

28.02.2011

Document type

PDF document, 416 kB, EN, not accessible

Download file : Executive summary (PDF document, 416 kB, EN, not accessible)
Rapid Report

Validity of surrogate endpoints in oncology (Rapid report)

published on

28.02.2011

Document type

PDF document, 2 MB, DE, not accessible

Download file : Rapid Report (PDF document, 2 MB, DE, not accessible)

Press releases

28.02.2011

How to recognize at an early stage whether a new cancer therapy prolongs life

Scientific methods for assessing surrogate endpoints are ready to be tested in practice / Appeal to researchers to analyse available studies

Project details

Project no.: A10-05
Commission: Commission awarded on 19.08.2010 by the Federal Joint Committee (GBA).
Report type: Rapid report
Status: Commission completed
Department/Division: Drug Assessment
Topic: Cancer

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Print page